Skip to main content
Clinical Trials/ISRCTN54865992
ISRCTN54865992
Completed
未知

mHealth for the early diagnosis and effective treatment of cutaneous leishmaniasis: a randomized trial comparing the completeness of assessment of adverse events and therapeutic outcome in those whose follow-up is supported by eHealth, versus standard of care, in parasitologically confirmed cases

Centro Internacional de Entrenamiento e Investigaciones Medicas0 sites104 target enrollmentOctober 8, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Cutaneous leishmaniasis (CL)
Sponsor
Centro Internacional de Entrenamiento e Investigaciones Medicas
Enrollment
104
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

2023 Results article in https://pubmed.ncbi.nlm.nih.gov/36972285/ results (added 28/03/2023)

Registry
who.int
Start Date
October 8, 2021
End Date
December 21, 2017
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Centro Internacional de Entrenamiento e Investigaciones Medicas

Eligibility Criteria

Inclusion Criteria

  • 1\. Residence in one of the three veredas (townships) previously identified as:
  • 1\.1\. Having a relatively high incidence of CL in the Colombia National System of Public Health Surveillance (SIVIGILA)
  • 1\.2\. Safe to work
  • 1\.3\. Relatively accessible
  • 2\. At least one cutaneous lesion

Exclusion Criteria

  • 1\. Mucosal leishmaniasis
  • 2\. Contraindication to receive treatment in the area of residence, i.e. with condition which requires treatment in the IPS

Outcomes

Primary Outcomes

Not specified

Similar Trials